Decoding Cancer: How Optiscan's ViewnVivo® is Transforming Research
Discover how Optiscan's ViewnVivo® is transforming cancer research in our latest article, authored by Dr. Camile Farah, Optiscan CEO.
"ViewnVivo® by Optiscan represents a significant leap forward in cancer research. It empowers researchers to delve deeper into the intricacies of the disease, unveiling its dynamic nature and hidden complexities."
Read the full article to learn how ViewnVivo® is transforming cancer research
Decoding Cancer: How Optiscan's ViewnVivo® is Transforming...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.020(9.09%) |
Mkt cap ! $167.0M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 20.0¢ | $29.60K | 142.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 44267 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 13834 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |